Hemispherx (HEB) Shares Tumble Amid Class Action Lawsuit by Shareholders
Tweet Send to a Friend
Shares of the volatile Hemispherx BioPharma (AMEX: HEB) are selling-off today as, last night, Dyer & Berens announced that it ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
